IBM Watson Health Launches Global Medical Imaging Collaboration to Target Cancer, Diabetes, Eye, Brain, and Heart Diseases

IBM recently announced the establishment of the IBM Watson Health Medical Imaging Collaboration, a global initiative comprising more than 15 leading healthcare institutions, academic medical centers, imaging diagnostics providers, and medical imaging technology companies. The initiative aims to integrate cognitive imaging technologies into the daily workflows of healthcare facilities, assisting physicians in diagnosing breast cancer, lung cancer, and other cancers, as well as diabetes, eye diseases, neurological disorders, heart disease, and related conditions such as stroke.

Members of the collaborative initiative leverage IBM Watson to extract insights from previously “invisible” unstructured imaging data and integrate them with vast amounts of data from other sources. This approach assists physicians in making personalized treatment decisions for individual patients while simultaneously building a knowledge base to benefit a broader patient population. Such information may include data extracted by IBM Watson from electronic health records, radiology and pathology reports, laboratory results, physicians’ progress notes, medical literature, clinical practice guidelines, and published conclusive reports.

Key members of the collaboration include Agfa HealthCare, Anne Arundel Medical Center, Baptist Health South Florida, Eastern Virginia Medical School, Hologic, Inc., Ifa systems AG, Inoveon, Radiology Associates of South Florida, Sentara Healthcare, Sheridan Healthcare, Topcon, UC San Diego Health, University of Miami Health System, University of Vermont Health Network, vRad (a MEDNAX affiliate), and Merge Healthcare (an IBM subsidiary). As the collaboration deepens, the latest achievements and intellectual contributions from these organizations and institutions will undoubtedly enhance IBM Watson’s core capabilities and insights.

As initially planned, IBM Watson will be trained and evaluated for potential new products applicable across various patient care settings, ranging from standalone mobility devices to integrated healthcare delivery networks. This initiative aims to collect data and share analytical insights based on real-world evidence supporting evidence-based medicine, thereby helping healthcare institutions identify and resolve operational and financial inefficiencies, optimize physician workflows, adopt patient-centered approaches to enhance care, and improve clinical outcomes. Furthermore, medical experts will assess how to facilitate the integration of IBM Watson into the existing medical IT systems of medical imaging technology companies participating in the program. For instance, by combining IBM Watson’s capabilities with electronic health records (EHRs) and Picture Archiving and Communication Systems (PACS), and embedding them into existing clinical workflows, cognitive insights can be provided to healthcare institutions.

Nadim Michel Daher, a medical imaging and intelligence analyst at Frost & Sullivan, stated, “Systems like IBM Watson hold immense potential to help radiologists improve work efficiency, diagnostic accuracy, decision-making quality, and cost manageability. Such collaborative projects are well-positioned to gather real-world evidence and case studies, thereby driving advancements in the field of medical imaging and meeting patient care needs in countries with high disease prevalence.”

IBM Watson Health aims to help healthcare institutions improve the utilization of medical imaging data, while providing cognitive products and services to enhance physicians’ ability to tailor treatment plans to each patient’s specific needs, thereby improving the quality of care.

Ms. Anne Le Grand recently joined IBM as Vice President of IBM Watson Health Imaging, bringing over 30 years of extensive experience in building multinational enterprises that span imaging, intelligence, diagnostics, and professional services. She stated, “Cognitive computing cloud can extract insights from vast amounts of integrated structured and unstructured data, thereby transforming how clinicians diagnose, treat, and monitor patients. Through IBM’s newly established Medical Imaging Collaboration Initiative, IBM Watson may enable clinicians to derive deeper insights and value from imaging data while better managing costs.”

How IBM Watson’s Imaging Data Analytics Capabilities Can Help Healthcare Institutions Achieve Clinical Transformation

Program members are expected to collaborate with cognitive computing experts from IBM Watson Health to train IBM Watson in assisting the treatment of cardiovascular diseases, ophthalmic conditions, and other illnesses. The population-based disease registry database contains millions of anonymized cases from around the world. To help create new solutions powered by IBM Watson, industry members of the Medical Imaging Collaboration Program can integrate IBM Watson into their workflow systems or image management software.

For example, Plan members can train IBM Watson to detect cardiovascular diseases at an early stage and identify commonly overlooked symptoms of heart disease, such as congestive heart failure or myocardial infarction (heart attack). To facilitate early disease detection, IBM Watson can be trained to analyze and “score” coronary angiograms (video images of the beating heart) for reference by internists. This score, often referred to as the “SYNTAX score,” serves as one of the key bases for internists to diagnose patients with coronary artery disease and determine whether to perform minimally invasive stent placement or bypass surgery.

For heart disease symptoms that are often overlooked, IBM Watson can be trained to “recognize” which symptoms indicate the onset of cardiac failure and continuously monitor disease progression, thereby enabling early detection of congestive heart failure.

Furthermore, IBM Watson can assist internists in correlating various types of chest pain with different health conditions, thereby determining whether the chest pain signals a potential heart attack. Chest pain is a primary cause of overcrowding in emergency departments at major hospitals annually. However, among the approximately 7 million patients who seek emergency care for chest pain each year, up to 2% suffer a heart attack at home after discharge due to having overlooked the warning signs of an acute cardiac event.

Ocular health is another key focus area of this collaborative initiative. Members participating in this effort will jointly work to develop evidence-based clinical decision support systems to assist ophthalmologists and optometrists in their practice. For instance, the online tools they have developed enable eye clinics and hospitals to early detect and monitor common ocular diseases among high-risk populations, such as screening for diabetic retinopathy in individuals with prediabetes or diabetes, as well as in patients with obesity or cardiovascular disease.

The initiative will further help IBM fulfill its commitment to working closely with healthcare professionals to co-develop medical solutions. For instance, IBM Watson for Oncology and IBM Watson Clinical Trial Matching have benefited from this program and represent the fruits of collaboration with the American Cancer Society, the American Diabetes Association, and the American Heart Association. IBM will establish its first IBM Watson Health European Center of Excellence near the Human Technopole Italy 2040 research campus in Milan, supporting the Italian government’s ambitious goal of creating an international hub that drives breakthroughs in genomics, big data, aging, and nutrition research.